Janet Shipley

27.2k total citations · 2 hit papers
216 papers, 11.1k citations indexed

About

Janet Shipley is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Janet Shipley has authored 216 papers receiving a total of 11.1k indexed citations (citations by other indexed papers that have themselves been cited), including 102 papers in Molecular Biology, 94 papers in Pulmonary and Respiratory Medicine and 49 papers in Pathology and Forensic Medicine. Recurrent topics in Janet Shipley's work include Sarcoma Diagnosis and Treatment (86 papers), Testicular diseases and treatments (34 papers) and Genomic variations and chromosomal abnormalities (24 papers). Janet Shipley is often cited by papers focused on Sarcoma Diagnosis and Treatment (86 papers), Testicular diseases and treatments (34 papers) and Genomic variations and chromosomal abnormalities (24 papers). Janet Shipley collaborates with scholars based in United Kingdom, United States and Germany. Janet Shipley's co-authors include Kathy Pritchard‐Jones, Yong‐Jie Lu, Robert Huddart, Brenda Summersgill, Sandra Gill, Jeremy Clark, Edoardo Missiaglia, Cyril Fisher, Barry A. Gusterson and A. Jayne Crew and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Nucleic Acids Research.

In The Last Decade

Janet Shipley

214 papers receiving 10.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Identification of novel genes, SYT and SSX, involved in the t(X;18)(p11.2;q11.2) translocation found in human synovial sarcoma

1994 606 citations Jeremy Clark, Janet Shipley et al. profile →
Rhabdomyosarcoma

2019 519 citations Stephen X. Skapek, Andrea Ferrari et al. profile →

Peers

Countries citing papers authored by Janet Shipley

Since Specialization

Citations

This map shows the geographic impact of Janet Shipley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janet Shipley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janet Shipley more than expected).

Fields of papers citing papers by Janet Shipley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Janet Shipley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janet Shipley. The network helps show where Janet Shipley may publish in the future.

Co-authorship network of co-authors of Janet Shipley

This figure shows the co-authorship network connecting the top 25 collaborators of Janet Shipley. A scholar is included among the top collaborators of Janet Shipley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Janet Shipley. Janet Shipley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Transcriptional regulation of genes by MYCN in PAX3::FOXO1-positive rhabdomyosarcomas and their roles in cell cycle progression 2025 ·ePrints Soton (University of Southampton) ·Zoë S. Walters, Daniel Leongamornlert, (unknown), (unknown), Reuben J. Pengelly, Ian Titley, Janet Shipley	0
2	The Capacity of Drug-Metabolising Enzymes in Modulating the Therapeutic Efficacy of Drugs to Treat Rhabdomyosarcoma 2024 ·Cancers ·(unknown), Muhammad Wahajuddin, Stefan Barth, Julia Chisholm, Janet Shipley, Klaus Pors	1
3	Clinicopathological Analysis of a European Cohort of MYOD1 Mutant Rhabdomyosarcomas in Children and Young Adults 2024 ·Pediatric Blood & Cancer ·Julia Chisholm, Joanna Selfe, Rita Alaggio, Edmund Cheesman, Angelica Zin, Lucia Tombolan, Antonina Parafioriti, Giuseppe Maria Milano, Madeleine Adams, (unknown), Maja Česen, Svetlana Tafjord, Meriel Jenney, Paula Proszek, Hélene Schlecht, (unknown), Janet Shipley, Anna Kelsey	3
4	Reappraisal of prognostic factors used in the European Pediatric Soft Tissue Sarcoma Study Group RMS 2005 study for localized rhabdomyosarcoma to optimize risk stratification and generate a prognostic nomogram 2024 ·Cancer ·Gian Luca De Salvo, Paola Del Bianco, Véronique Minard‐Colin, Julia Chisholm, Meriel Jenney, Gabriela Guillén, Christine Devalck, Rick R. van Rijn, Janet Shipley, Daniel Orbach, Anna Kelsey, Timothy Rogers, Florent Guérin, Giovanni Scarzello, Andrea Ferrari, Maja Česen, Johannes H. M. Merks, Gianni Bisogno, (unknown)	8
5	Genomic and Epigenetic Changes Drive Aberrant Skeletal Muscle Differentiation in Rhabdomyosarcoma 2023 ·Cancers ·Silvia Pomella, (unknown), Rita Alaggio, Willemijn B. Breunis, (unknown), Joanna Selfe, Marco Wachtel, Zoë S. Walters, Beat W. Schäfer, Rossella Rota, Janet Shipley, Simone Hettmer	3
6	Biological Role and Clinical Implications of MYOD1L122R Mutation in Rhabdomyosarcoma 2023 ·Cancers ·(unknown), Julia Chisholm, Anna Kelsey, Rita Alaggio, Gianni Bisogno, Véronique Minard‐Colin, Meriel Jenney, Raquel Dávila Fajardo, Johannes H. M. Merks, Janet Shipley, Joanna Selfe	10
7	Endo180 ( MRC2 ) Antibody–Drug Conjugate for the Treatment of Sarcoma 2022 ·Molecular Cancer Therapeutics ·(unknown), (unknown), Joanna Selfe, Anna Kelsey, (unknown), Janet Shipley, Koen Schipper, Clare M. Isacke	5
8	Shedding a Light on the Challenges of Adolescents and Young Adults with Rhabdomyosarcoma 2022 ·Cancers ·Andrea Ferrari, Susanne A. Gatz, Véronique Minard‐Colin, Rita Alaggio, (unknown), Daniel Orbach, Patrizia Gasparini, Anne Sophie Defachelles, Michela Casanova, Giuseppe Maria Milano, Julia Chisholm, Meriel Jenney, Gianni Bisogno, Timothy Rogers, Henry Mandeville, Janet Shipley, Aisha Miah, Johannes H. M. Merks, Winette T.A. van der Graaf	6
9	Pathology of childhood rhabdomyosarcoma: A consensus opinion document from the Children's Oncology Group, European Paediatric Soft Tissue Sarcoma Study Group, and the Cooperative Weichteilsarkom Studiengruppe 2020 ·Pediatric Blood & Cancer ·Erin R. Rudzinski, Anna Kelsey, Christian Vokuhl, Corinne M. Linardic, Janet Shipley, Simone Hettmer, Ewa Kościelniak, Douglas S. Hawkins, Gianni Bisogno	43
10	ATR Is a Therapeutic Target in Synovial Sarcoma 2017 ·Cancer Research ·Samuel E. Jones, Emmy D.G. Fleuren, Jessica Frankum, Asha Konde, Chris T. Williamson, Dragomir B. Krastev, Helen N. Pemberton, James Campbell, Aditi Gulati, Richard Elliott, Malini Menon, Joanna Selfe, Rachel Brough, Stephen J. Pettitt, Wojciech Niedźwiedź, Winette T.A. van der Graaf, Janet Shipley, Alan Ashworth, Christopher J. Lord	47
11	Clinical Application of Prognostic Gene Expression Signature in Fusion Gene–Negative Rhabdomyosarcoma: A Report from the Children's Oncology Group 2015 ·Clinical Cancer Research ·Pooja Hingorani, Edoardo Missiaglia, Janet Shipley, James R. Anderson, Timothy J. Triche, Mauro Delorenzi, Julie M. Gastier‐Foster, Michele R. Wing, Douglas S. Hawkins, Stephen X. Skapek	17
12	Defining a New Prognostic Index for Stage I Nonseminomatous Germ Cell Tumors Using CXCL12 Expression and Proportion of Embryonal Carcinoma 2015 ·Clinical Cancer Research ·Duncan C. Gilbert, Reem Al‐Saadi, Khin Thway, Ian Chandler, Daniel M. Berney, Rhian Gabe, Sally Stenning, Joan Sweet, Robert Huddart, Janet Shipley	18
13	Distinct Effects of Ligand-Induced PDGFRα and PDGFRβ Signaling in the Human Rhabdomyosarcoma Tumor Cell and Stroma Cell Compartments 2013 ·Cancer Research ·Monika Ehnman, Edoardo Missiaglia, Erika Folestad, Joanna Selfe, Carina Strell, Khin Thway, Bertha Brodin, Kristian Pietras, Janet Shipley, Arne Östman, Ulf Eriksson	73
14	Dual Blockade of the PI3K/AKT/mTOR (AZD8055) and RAS/MEK/ERK (AZD6244) Pathways Synergistically Inhibits Rhabdomyosarcoma Cell Growth In Vitro and In Vivo 2013 ·Clinical Cancer Research ·Jane Renshaw, Kathryn R. Taylor, Ryan T. Bishop, Melanie Valenti, Alexis de Haven Brandon, Sharon Gowan, Suzanne A. Eccles, Ruth Ruddle, Louise D. Johnson, Florence I. Raynaud, Joanna Selfe, Khin Thway, Torsten Pietsch, Andrew D.J. Pearson, Janet Shipley	110
15	PAX3/FOXO1 Fusion Gene Status Is the Key Prognostic Molecular Marker in Rhabdomyosarcoma and Significantly Improves Current Risk Stratification 2012 ·Journal of Clinical Oncology ·Edoardo Missiaglia, Dan Williamson, Julia Chisholm, Pratyaksha Wirapati, Gaëlle Pierron, Fabien Petel, Jean‐Paul Concordet, Khin Thway, Odile Oberlin, Kathy Pritchard‐Jones, Olivier Delattre, Mauro Delorenzi, Janet Shipley	230
16	Fusion Gene–Negative Alveolar Rhabdomyosarcoma Is Clinically and Molecularly Indistinguishable From Embryonal Rhabdomyosarcoma 2010 ·Journal of Clinical Oncology ·Daniel Williamson, Edoardo Missiaglia, Aurélien de Reyniès, Gaëlle Pierron, Bénédicte Thuille, Gilles Palenzuela, Khin Thway, Daniel Orbach, Marick Laé, Paul Fréneaux, Kathy Pritchard‐Jones, Odile Oberlin, Janet Shipley, Olivier Delattre	326
17	Role for Amplification and Expression of Glypican-5 in Rhabdomyosarcoma 2007 ·Cancer Research ·Daniel Williamson, Joanna Selfe, Tony Gordon, Yong‐Jie Lu, Kathy Pritchard‐Jones, Kasumi Murai, Philip H. Jones, Paul Workman, Janet Shipley	77
18	Genomic and Expression Profiling of Human Spermatocytic Seminomas: Primary Spermatocyte as Tumorigenic Precursor and DMRT1 as Candidate Chromosome 9 Gene 2006 ·Cancer Research ·Leendert H. J. Looijenga, Remko Hersmus, Ad Gillis, Rolph Pfundt, Hans Stoop, Ruud J. H. L. M. van Gurp, Joris A. Veltman, H. Berna Beverloo, Ellen van Drunen, Ad Geurts van Kessel, Renee A. Reijo Pera, Dominik T. Schneider, Brenda Summersgill, Janet Shipley, Alan McIntyre, Peter J. van der Spek, Eric Schoenmakers, J. Wolter Oosterhuis	170
19	The MET receptor tyrosine kinase contributes to invasive tumour growth in rhabdomyosarcomas 2006 ·Growth Factors ·(unknown), Daniel Williamson, (unknown), Nipurna Jina, (unknown), Janet Shipley, John Anderson	31
20	A Gene Expression Signature Associated with Metastatic Outcome in Human Leiomyosarcomas 2004 ·Cancer Research ·Yin-Fai Lee, (unknown), Alison Falconer, S M Edwards, Jeremy Clark, Penny Flohr, Toby Roe, Rubin Wang, Janet Shipley, R. J. Grimer, D. Chas Mangham, Joseph Thomas, Cyril Fisher, Ian Judson, Colin S. Cooper	59

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact